CERECIN INC.

Profile

Company Names

CERECIN INC.
ACCERA INC

Addresses

44 COOK STREET, SUITE 100-71, DENVER, CO 80206

3005 CENTER GREEN DRIVE, SUITE 205, BOULDER, CO 80301

380 INTERLOCKEN CRESCENT, SUITE 780, BROOMFIELD, CO 80021

Phone Numbers

(303) 999-3700
303-999-3700
303-439-0004

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

DE

Total Amount Raised:

$188,003,370.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2024-06-10 
$3,740,000.00 
$7,000,000.00 
$3,260,000.00 
Debt 
10
2022-08-03 
$7,220,002.00 
$39,999,999.00 
$32,779,997.00 
Equity 
9
2021-09-14 
$10,000,001.00 
$30,000,000.00 
$19,999,999.00 
Equity 
8
2021-01-21 
$10,000,000.00 
$14,999,935.00 
$4,999,935.00 
Equity 
7
2018-02-09 
$17,639,537.00 
$50,139,527.00 
$32,499,990.00 
Equity 
6
2012-07-17 
$84,081,610.00 
$84,081,610.00 
$0.00 
Equity, Debt 
5
2012-04-18 
$4,882,125.00 
$4,882,125.00 
$0.00 
Debt 
4
2011-10-10 
$3,900,787.00 
$3,900,787.00 
$0.00 
Debt 
3
2010-12-07 
$11,000,000.00 
$11,000,000.00 
$0.00 
Equity 
2
2010-03-02 
$9,487,313.00 
$9,487,313.00 
$0.00 
Equity 
1
2008-11-19 
$26,051,995.00 
$35,170,200.00 
$9,118,205.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EVAN 
 
BALLANTYNE 
EXECUTIVE OFFICER
GREG 
 
BEHAR 
DIRECTOR
LUIS 
 
CANTARELL 
DIRECTOR
SAMUEL 
T. 
HENDERSON 
EXECUTIVE OFFICER
GARY 
 
HOOPER 
DIRECTOR
GREGORY 
J. 
KADING 
EXECUTIVE OFFICER
KIKAB 
 
KIM 
DIRECTOR
JERRIS 
 
KNAISCH 
EXECUTIVE OFFICER
HOLGER 
 
KUNZE 
EXECUTIVE OFFICER, DIRECTOR
CLAUDE 
 
NASH 
DIRECTOR
CLAUDE 
NASH 
DIRECTOR
STEVE 
 
ORNDORFF 
EXECUTIVE OFFICER, DIRECTOR
RAHUL 
 
RAJASHEKAR 
DIRECTOR
WOLFGANG 
 
REICHENBERGER 
DIRECTOR
ROBERT 
 
SCHIER 
DIRECTOR
DILPREET 
 
SINGH 
EXECUTIVE OFFICER
CHARLES 
 
STACEY 
EXECUTIVE OFFICER, DIRECTOR
NICHOLAS 
CHARLES 
STACEY 
EXECUTIVE OFFICER, DIRECTOR
SVEN 
 
THORMAHLEN 
DIRECTOR
MILAN 
 
VINNOLA 
EXECUTIVE OFFICER
GURPREET 
 
VOHRA 
DIRECTOR
GURPREET 
SINGH 
VOHRA 
DIRECTOR
GUNNAR 
 
WEIKERT 
DIRECTOR
THOMAS 
 
WERNER 
DIRECTOR, EXECUTIVE OFFICER
HANS-JUERGEN 
 
WOERLE 
DIRECTOR
HANS-JURGEN 
 
WOERLE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2024-06-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-21 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-09 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-07-17 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-07-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-07-17 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-07-17 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-07-17 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2011-10-10 
D
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2012-04-18 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-07 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-02 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2008-11-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#